Talecris to announce expansion, shares company results
Talecris Biotherapeutics is poised to announce a plan to expand its plant in North Carolina. The first phase of the expansion is anticipated to be a $280 million facility for the separation of blood plasma proteins used in drug development. The company also reported an increase in revenue and profit during the third quarter, owing to sales of its blood plasma-derived drug products.
News & Observer (Raleigh, N.C.), The
| 11/10
This story published in BIO SmartBrief on 11/13/2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|